DCC buys generic drugmaker for €68m

Support services giant DCC has strengthened its healthcare division with the €68.1m takeover of Kent Pharmaceutical — the largest manufacturer of generic medical treatments.

The Dublin-headquartered group could end up paying almost €75m for the British firm — which also has a manufacturing facility in Roscommon.

It will pay the €68.1m as an initial consideration; but could pay a deferred consideration of up to €6.7m depending on the future performance of the Kent business.